Skip to main content

Richard Francis Riedel

Professor of Medicine
Medicine, Medical Oncology
Duke Box 3198, Durham, NC 27710
Dept of Medicine, 25178 Morris Bldg, Durham, NC 27710

Overview


Novel therapies for soft tissue and bone sarcomas

Current Appointments & Affiliations


Professor of Medicine · 2024 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2000 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published March 4, 2015
Dr. Richard Riedel: Early palliative care can cut hospital re-admissions for cancer patients
Published November 7, 2014
Duke revolutionizes cancer care, garners national attention
Published October 22, 2014
Early Palliative Care Can Cut Hospital Readmissions for Cancer Patients

View All News

Recent Publications


Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma.

Journal Article Clin Cancer Res · June 3, 2025 PURPOSE: Comprehensive molecular profiling was used to define the genomic and immune landscapes of leiomyosarcomas (LMS) by anatomic subtypes, which have not been completely characterized. EXPERIMENTAL DESIGN: A total of 1,115 LMS samples, categorized into ... Full text Link to item Cite

Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities.

Conference Oncologist · December 6, 2024 BACKGROUND: Malignant phyllodes tumors (MPT) are rare fibroepithelial breast cancers with no known effective systemic therapy; metastatic progression portends a dismal prognosis. We sought to describe the genomic landscape of MPTs through genomic profiling ... Full text Link to item Cite

Prospective evaluation of quantitative response parameter in patients with Gastrointestinal Stroma Tumor undergoing tyrosine kinase inhibitor therapy-Impact on clinical outcome.

Journal Article Int J Cancer · December 1, 2024 The purpose of this study was to determine if dual-energy CT (DECT) vital iodine tumor burden (ViTB), a direct assessment of tumor vascularity, allows reliable response assessment in patients with GIST compared to established CT criteria such as RECIST1.1 ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


Thomas Jefferson University · 2000 M.D.